MedPath

Bioimpedance Analysis Guided Volume Expansion for the Prevention of Contrast Induced-acute Kidney Injury

Not Applicable
Completed
Conditions
X-ray Contrast Media Adverse Reaction
Registration Number
NCT02449317
Lead Sponsor
Mahidol University
Brief Summary

Bioelectrical impedance analysis guided volume expansion for the prevention of contrast induced-acute kidney injury

Detailed Description

Compared bioelectrical impedance analysis guided hydration therapy versus standard hydration for the prevention of contrast induced-acute kidney injury

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria
  1. Age 18-90 yr
  2. Chronic kidney disease stage 3 & 4 (eGFR 15-60 ml/min/m2)
  3. elective cardiac catheterization
Exclusion Criteria
  1. Contrast media administration in the past 14 days
  2. congestive heart failure (NYHA III-IV, ascites , pleuropericardial effusion ,severe valvular heart disease
  3. Kidney transplant status or RRT
  4. Emergency cardiac catheterization
  5. Allergy to radiographic contrast media
  6. Unstable renal function (change in serum creatinine ≥ 0.5 mg/dl or 25% within 14 days prior to the study
  7. Not inform consent
  8. left ventricular ejection fraction < 40 %
  9. Liver cirrhosis child B or C
  10. Dosage of angiotensin-converting enzyme inhibitor /angiotensin II receptor blocker changed in past 2 wk

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
serum creatinine at 48-72 hours after contrast administration48-72 hr

Acute kidney injury

Secondary Outcome Measures
NameTimeMethod
serum creatinine at 2 weeks after contrast administration2 weeks

Renal replacement therapy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.